CONMED CORPORATION Deferred Tax Liabilities, Gross
CONMED CORPORATION (CNMD) had Deferred Tax Liabilities, Gross of $179.88 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-17
- 2025-12-31: Deferred Tax Liabilities, Gross $179.88M.
- 2024-12-31: Deferred Tax Liabilities, Gross $177.17M.
- 2023-12-31: Deferred Tax Liabilities, Gross $170.17M.
- 2022-12-31: Deferred Tax Liabilities, Gross $170.41M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $179.88M 10-K · filed 2026-02-17 |
| 2024-12-31 | $177.17M 10-K · filed 2026-02-17 |
| 2023-12-31 | $170.17M 10-K · filed 2025-02-18 |
| 2022-12-31 | $170.41M 10-K · filed 2024-02-28 |
| 2021-12-31 | $131.29M 10-K · filed 2023-02-21 |
| 2020-12-31 | $130.04M 10-K · filed 2022-02-22 |
| 2019-12-31 | $130.53M 10-K · filed 2021-02-22 |
| 2018-12-31 | $117.25M 10-K · filed 2020-02-24 |
| 2017-12-31 | $123.18M 10-K · filed 2019-02-25 |
| 2016-12-31 | $187.87M 10-K · filed 2018-02-26 |
| 2015-12-31 | $142.25M 10-K · filed 2017-02-27 |
| 2014-12-31 | $141.06M 10-K · filed 2016-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |